查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1586178

细胞解离市场：按产品类型、组织和最终用户划分 - 全球预测 2025-2030

Cell Dissociation Market by Product (Enzymatic Dissociation Products, Instruments & Accessories, Non-Enzymatic Dissociation Products), Type (Cell Detachment, Tissue Dissociation), Tissue, End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 192 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年细胞解离市场价值为7.5932亿美元，预计到2024年将达到8.786亿美元，复合年增长率为16.91%，到2030年将达到22.6764亿美元。

细胞解离是指从组织或培养物中释放细胞的过程，通常透过酵素、化学或机械方法完成。此步骤对于多种应用至关重要，包括用于检测的细胞製备、单细胞 RNA 定序、干细胞研究和治疗开发。细胞解离的必要性在于它的作用可以让研究人员和临床医生在隔离的环境中研究细胞的行为和功能，从而显着加深我们对细胞生物学的理解并提高实验结果的准确性。最终用途包括学术研究、製药和生物技术行业，特别是在再生医学和癌症研究中的用途越来越多。

主要市场统计
基准年[2023] 75932万美元
预测年份 [2024] 8.786 亿美元
预测年份 [2030] 22.6764亿美元
复合年增长率（%） 16.91%

细胞分离市场受到多种成长要素的推动，包括生物技术的进步、对精准医疗的日益关注以及需要先进治疗性介入的慢性疾病盛行率的上升。开发细胞友善的非酶解方法和整合自动化流程以提高效率和重现性存在新的机会。利用这些机会的主要建议包括投资创新解离技术的研发以及与专注于尖端细胞生物学研究的机构建立策略联盟。

然而，该市场受到与先进解离技术相关的高成本、监管挑战以及某些解离技术可能影响细胞活力和功能所造成的潜在细胞损伤的限制。随着公司努力克服这些障碍，对提高解离后细胞存活率的研究和改进技术以最大限度地减少细胞压力正在推动创新，这是一个充满可能性的领域。

市场动态是动态的，其特点是技术的快速进步以及研究活动中对永续性和道德考虑的日益重视。调整策略以解决这些领域问题，同时适应监管环境并专注于具有成本效益的解决方案的公司将在这个不断发展的市场中获得竞争优势。

市场动态：揭示快速发展的细胞分离市场的关键市场洞察

供需的动态交互作用正在改变细胞分离市场。了解这些不断变化的市场动态可以帮助企业做出明智的投资决策、策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时消费行为及其对製造成本的影响以及对采购趋势的影响。

  • 市场驱动因素
    • 製药和生物製药公司基于细胞的研究活动的扩展
    • 慢性病和感染疾病的发生率和发生率增加
    • 政府资助干细胞研究活动的情况
  • 市场限制因素
    • 组织和细胞治疗方法的高成本
  • 市场机会
    • 持续推出先进的细胞分离产品
    • 细胞解离开发的监管核准增加
  • 市场挑战
    • 低度开发国家细胞研究基础设施有限

波特的五力：驾驭细胞分离市场的策略工具

波特的五力框架是了解细胞分离市场竞争格局的关键工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解细胞分离市场的外部影响

外部宏观环境因素在塑造细胞分离市场的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并为他们做出积极主动的决策做好准备。

市场占有率分析 了解细胞分离市场的竞争状况

细胞分离市场的详细市场占有率分析可以对供应商的绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，以应对日益激烈的竞争。

FPNV定位矩阵细胞解离市场供应商绩效评估

FPNV定位矩阵是评估细胞解离市场供应商的重要工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，以确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议描绘了细胞分离市场的成功之路

细胞分离市场的策略分析对于旨在加强其在全球市场的影响力的公司至关重要。透过考虑关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：详细检视当前市场环境、主要企业的广泛资料、评估其在市场中的影响力和整体影响力。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 基于细胞的研究活动在製药和生物製药公司中越来越受欢迎
      • 慢性病和感染疾病和盛行率上升
      • 政府资助干细胞研究活动的情况
    • 抑制因素
      • 基于组织和细胞的治疗高成本
    • 机会
      • 持续推出先进的细胞分离产品
      • 细胞解离开发的监管核准增加
    • 任务
      • 开发中国家缺乏细胞研究基础设施
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章细胞分离市场：副产品

  • 酵素降解产物
    • 胶原酶
    • 去氧核醣核酸酶
    • 弹性蛋白酶
    • 玻糖醛酸酶
    • 木瓜蛋白酶
    • 胰蛋白酶
  • 乐器及配件
  • 非酵素降解产物

第七章细胞分离市场：依类型

  • 细胞脱离
  • 组织解离

第8章 细胞解离市场组织

  • 结缔组织
  • 上皮组织
  • 骨骼和肌肉组织

第九章细胞分离市场：依最终用户分类

  • 製药和生物技术公司
  • 研究和学术

第十章美洲细胞分离市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十一章亚太细胞分离市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十二章欧洲、中东和非洲的细胞解离市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十三章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
    • 安捷伦宣布收​​购电子捕获解离技术公司
    • S2 Genomics 与 Techtum Lab AB 签署经销协议，为斯堪的斯堪地那维亚地区提供服务
    • Applied Cells 与 Stem Cell Technologies 签署下一代细胞分离解决方案所使用试剂组供应协议
    • LevitasBio 宣布 LeviPrep 和 LeviSelect 产品线
  • 战略分析和建议

公司名单

  • Abeomics Inc.
  • AcceGen
  • ACROBiosystems Group
  • ALSTEM
  • AMS Biotechnology
  • Becton, Dickinson and Company
  • Bio-Techne Corporation
  • Biogenuix Medsystems Pvt. Ltd.
  • Capricorn Scientific
  • Captivate Bio, LLC
  • Cell Signaling Technology, Inc.
  • Cellseco Ltd.
  • Cellsystems Gmbh
  • Celprogen Corporation
  • Central Drug House.（P）Ltd.
  • Corning Inc.
  • Creative Bioarray
  • Cytori Therapeutics Inc.
  • Diagnocine
  • F. Hoffmann-La Roche Ltd.
  • FlowMetric, Inc.
  • Gemini BioProducts LLC
  • Genaxxon bioscience GmbH
  • Genlantis Inc.
  • Genomics, Inc.
  • HiMedia Laboratories Private Limited
  • Innovative Cell Technologies, Inc.
  • Krackeler Scientific, Inc.
  • Merck KGaA
  • Miltenyi Biotec BV & Co. KG
  • MP Biomedicals, LLC
  • Nacalai Tesque, Inc.
  • Neuromics
  • Nordmark Pharma GmbH
  • PAN-Biotech GmbH
  • PELOBIOTECH GmbH
  • PromoCell GmbH
  • Protein Ark Ltd. by CalibreScientific
  • REPROCELL Inc.
  • RWD Life Science Co., Ltd.
  • Sartorius AG
  • ScienCell Research Laboratories, Inc.
  • Singleron Biotechnologies GmbH
  • STEMCELL Group
  • Stemmera Inc.
  • Tebubio
  • Thermo Fisher Scientific Inc.
  • VitaCyte, LLC
  • VWR International, LLC
  • Worthington Biochemical Corporation
Product Code: MRR-46132FF79DDC

The Cell Dissociation Market was valued at USD 759.32 million in 2023, expected to reach USD 878.60 million in 2024, and is projected to grow at a CAGR of 16.91%, to USD 2,267.64 million by 2030.

Cell dissociation refers to the process of releasing cells from tissues or cultures, typically achieved through enzymatic, chemical, or mechanical methods. This procedure is crucial for various applications, including cell preparation for assays, single-cell RNA sequencing, stem cell research, and therapeutic developments. The necessity of cell dissociation lies in its role in enabling researchers and clinicians to study cellular behaviors and functions in isolated environments, which significantly enhances the understanding of cellular biology and improves the accuracy of experimental outcomes. The end-use scope spans academic research, pharmaceutical and biotechnology industries, with expanding use in regenerative medicine and cancer research being particularly notable.

KEY MARKET STATISTICS
Base Year [2023] USD 759.32 million
Estimated Year [2024] USD 878.60 million
Forecast Year [2030] USD 2,267.64 million
CAGR (%) 16.91%

The market for cell dissociation is propelled by several growth factors, including advancements in biotechnology, the increasing focus on precision medicine, and the rising prevalence of chronic diseases that necessitate advanced therapeutic interventions. Emerging opportunities exist in the development of non-enzymatic dissociation methods that are gentler on cells and the integration of automated processes to increase efficiency and reproducibility. Key recommendations to exploit these opportunities include investment in R&D for innovative dissociation technologies and strategic partnerships with institutions focusing on cutting-edge cell biology research.

However, the market faces limitations such as high costs associated with advanced dissociation technologies, regulatory challenges, and potential cell damage caused by certain dissociation techniques that can affect cell viability and functionality. As companies strive to overcome these hurdles, emphasis on research to improve cell viability post-dissociation and the refinement of techniques to minimize cell stress are potential areas of innovation.

The cell dissociation market is dynamic, characterized by rapid technological advancements and a growing emphasis on sustainability and ethical considerations in research practices. Companies that align their strategies to address these areas while navigating regulatory landscapes and focusing on cost-effective solutions stand to gain a competitive edge in this evolving market.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Cell Dissociation Market

The Cell Dissociation Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Growing prevalence of cell based research activities across pharmaceutical and biopharmaceutical companies
    • Rising incidence and prevalence of chronic and infectious diseases
    • Availability of government funding for stem-cell research activities
  • Market Restraints
    • High cost of tissue and cell based procedures
  • Market Opportunities
    • Ongoing introduction of advanced cell dissociation products
    • Rising regulatory approvals for the cell dissociation developments
  • Market Challenges
    • Limited infrastructure for the cell-based research in underdeveloped countries

Porter's Five Forces: A Strategic Tool for Navigating the Cell Dissociation Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Cell Dissociation Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Cell Dissociation Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Cell Dissociation Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Cell Dissociation Market

A detailed market share analysis in the Cell Dissociation Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Cell Dissociation Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Cell Dissociation Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Cell Dissociation Market

A strategic analysis of the Cell Dissociation Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Cell Dissociation Market, highlighting leading vendors and their innovative profiles. These include Abeomics Inc., AcceGen, ACROBiosystems Group, ALSTEM, AMS Biotechnology, Becton, Dickinson and Company, Bio-Techne Corporation, Biogenuix Medsystems Pvt. Ltd., Capricorn Scientific, Captivate Bio, LLC, Cell Signaling Technology, Inc., Cellseco Ltd., Cellsystems Gmbh, Celprogen Corporation, Central Drug House. (P) Ltd., Corning Inc., Creative Bioarray, Cytori Therapeutics Inc., Diagnocine, F. Hoffmann-La Roche Ltd., FlowMetric, Inc., Gemini BioProducts LLC, Genaxxon bioscience GmbH, Genlantis Inc., Genomics, Inc., HiMedia Laboratories Private Limited, Innovative Cell Technologies, Inc., Krackeler Scientific, Inc., Merck KGaA, Miltenyi Biotec B.V. & Co. KG, MP Biomedicals, LLC, Nacalai Tesque, Inc., Neuromics, Nordmark Pharma GmbH, PAN-Biotech GmbH, PELOBIOTECH GmbH, PromoCell GmbH, Protein Ark Ltd. by CalibreScientific, REPROCELL Inc., RWD Life Science Co., Ltd., Sartorius AG, ScienCell Research Laboratories, Inc., Singleron Biotechnologies GmbH, STEMCELL Group, Stemmera Inc., Tebubio, Thermo Fisher Scientific Inc., VitaCyte, LLC, VWR International, LLC, and Worthington Biochemical Corporation.

Market Segmentation & Coverage

This research report categorizes the Cell Dissociation Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Enzymatic Dissociation Products, Instruments & Accessories, and Non-Enzymatic Dissociation Products. The Enzymatic Dissociation Products is further studied across Collagenase, DNase, Elastase, Hyaluronidase, Papain, and Trypsin.
  • Based on Type, market is studied across Cell Detachment and Tissue Dissociation.
  • Based on Tissue, market is studied across Connective Tissues, Epithelial Tissues, and Skeletal & Muscles Tissues.
  • Based on End-User, market is studied across Pharmaceutical & Biotechnology Companies and Research & Academics.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing prevalence of cell based research activities across pharmaceutical and biopharmaceutical companies
      • 5.1.1.2. Rising incidence and prevalence of chronic and infectious diseases
      • 5.1.1.3. Availability of government funding for stem-cell research activities
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of tissue and cell based procedures
    • 5.1.3. Opportunities
      • 5.1.3.1. Ongoing introduction of advanced cell dissociation products
      • 5.1.3.2. Rising regulatory approvals for the cell dissociation developments
    • 5.1.4. Challenges
      • 5.1.4.1. Limited infrastructure for the cell-based research in underdeveloped countries
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Cell Dissociation Market, by Product

  • 6.1. Introduction
  • 6.2. Enzymatic Dissociation Products
    • 6.2.1. Collagenase
    • 6.2.2. DNase
    • 6.2.3. Elastase
    • 6.2.4. Hyaluronidase
    • 6.2.5. Papain
    • 6.2.6. Trypsin
  • 6.3. Instruments & Accessories
  • 6.4. Non-Enzymatic Dissociation Products

7. Cell Dissociation Market, by Type

  • 7.1. Introduction
  • 7.2. Cell Detachment
  • 7.3. Tissue Dissociation

8. Cell Dissociation Market, by Tissue

  • 8.1. Introduction
  • 8.2. Connective Tissues
  • 8.3. Epithelial Tissues
  • 8.4. Skeletal & Muscles Tissues

9. Cell Dissociation Market, by End-User

  • 9.1. Introduction
  • 9.2. Pharmaceutical & Biotechnology Companies
  • 9.3. Research & Academics

10. Americas Cell Dissociation Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Cell Dissociation Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Cell Dissociation Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
    • 13.3.1. Agilent Announces Acquisition of Company Behind Electron Capture Dissociation Technology
    • 13.3.2. S2 Genomics Announces Distribution Agreement with Techtum Lab AB to Serve Scandinavia
    • 13.3.3. Applied Cells Enters into a Supply Agreement with STEMCELL Technologies on Reagent Kits for Use in a Next-Generation Solution for Cell Separation
    • 13.3.4. LevitasBio Unveils LeviPrep and LeviSelect Product Lines
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abeomics Inc.
  • 2. AcceGen
  • 3. ACROBiosystems Group
  • 4. ALSTEM
  • 5. AMS Biotechnology
  • 6. Becton, Dickinson and Company
  • 7. Bio-Techne Corporation
  • 8. Biogenuix Medsystems Pvt. Ltd.
  • 9. Capricorn Scientific
  • 10. Captivate Bio, LLC
  • 11. Cell Signaling Technology, Inc.
  • 12. Cellseco Ltd.
  • 13. Cellsystems Gmbh
  • 14. Celprogen Corporation
  • 15. Central Drug House. (P) Ltd.
  • 16. Corning Inc.
  • 17. Creative Bioarray
  • 18. Cytori Therapeutics Inc.
  • 19. Diagnocine
  • 20. F. Hoffmann-La Roche Ltd.
  • 21. FlowMetric, Inc.
  • 22. Gemini BioProducts LLC
  • 23. Genaxxon bioscience GmbH
  • 24. Genlantis Inc.
  • 25. Genomics, Inc.
  • 26. HiMedia Laboratories Private Limited
  • 27. Innovative Cell Technologies, Inc.
  • 28. Krackeler Scientific, Inc.
  • 29. Merck KGaA
  • 30. Miltenyi Biotec B.V. & Co. KG
  • 31. MP Biomedicals, LLC
  • 32. Nacalai Tesque, Inc.
  • 33. Neuromics
  • 34. Nordmark Pharma GmbH
  • 35. PAN-Biotech GmbH
  • 36. PELOBIOTECH GmbH
  • 37. PromoCell GmbH
  • 38. Protein Ark Ltd. by CalibreScientific
  • 39. REPROCELL Inc.
  • 40. RWD Life Science Co., Ltd.
  • 41. Sartorius AG
  • 42. ScienCell Research Laboratories, Inc.
  • 43. Singleron Biotechnologies GmbH
  • 44. STEMCELL Group
  • 45. Stemmera Inc.
  • 46. Tebubio
  • 47. Thermo Fisher Scientific Inc.
  • 48. VitaCyte, LLC
  • 49. VWR International, LLC
  • 50. Worthington Biochemical Corporation

LIST OF FIGURES

  • FIGURE 1. CELL DISSOCIATION MARKET RESEARCH PROCESS
  • FIGURE 2. CELL DISSOCIATION MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL CELL DISSOCIATION MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL CELL DISSOCIATION MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL CELL DISSOCIATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL CELL DISSOCIATION MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL CELL DISSOCIATION MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL CELL DISSOCIATION MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL CELL DISSOCIATION MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL CELL DISSOCIATION MARKET SIZE, BY TISSUE, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL CELL DISSOCIATION MARKET SIZE, BY TISSUE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL CELL DISSOCIATION MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL CELL DISSOCIATION MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS CELL DISSOCIATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS CELL DISSOCIATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES CELL DISSOCIATION MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES CELL DISSOCIATION MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC CELL DISSOCIATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC CELL DISSOCIATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA CELL DISSOCIATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA CELL DISSOCIATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. CELL DISSOCIATION MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. CELL DISSOCIATION MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. CELL DISSOCIATION MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL CELL DISSOCIATION MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL CELL DISSOCIATION MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL CELL DISSOCIATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. CELL DISSOCIATION MARKET DYNAMICS
  • TABLE 7. GLOBAL CELL DISSOCIATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL CELL DISSOCIATION MARKET SIZE, BY ENZYMATIC DISSOCIATION PRODUCTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL CELL DISSOCIATION MARKET SIZE, BY COLLAGENASE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL CELL DISSOCIATION MARKET SIZE, BY DNASE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL CELL DISSOCIATION MARKET SIZE, BY ELASTASE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL CELL DISSOCIATION MARKET SIZE, BY HYALURONIDASE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL CELL DISSOCIATION MARKET SIZE, BY PAPAIN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL CELL DISSOCIATION MARKET SIZE, BY TRYPSIN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL CELL DISSOCIATION MARKET SIZE, BY ENZYMATIC DISSOCIATION PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL CELL DISSOCIATION MARKET SIZE, BY INSTRUMENTS & ACCESSORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL CELL DISSOCIATION MARKET SIZE, BY NON-ENZYMATIC DISSOCIATION PRODUCTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL CELL DISSOCIATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL CELL DISSOCIATION MARKET SIZE, BY CELL DETACHMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL CELL DISSOCIATION MARKET SIZE, BY TISSUE DISSOCIATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL CELL DISSOCIATION MARKET SIZE, BY TISSUE, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL CELL DISSOCIATION MARKET SIZE, BY CONNECTIVE TISSUES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL CELL DISSOCIATION MARKET SIZE, BY EPITHELIAL TISSUES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL CELL DISSOCIATION MARKET SIZE, BY SKELETAL & MUSCLES TISSUES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL CELL DISSOCIATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL CELL DISSOCIATION MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL CELL DISSOCIATION MARKET SIZE, BY RESEARCH & ACADEMICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS CELL DISSOCIATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS CELL DISSOCIATION MARKET SIZE, BY ENZYMATIC DISSOCIATION PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 30. AMERICAS CELL DISSOCIATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 31. AMERICAS CELL DISSOCIATION MARKET SIZE, BY TISSUE, 2018-2030 (USD MILLION)
  • TABLE 32. AMERICAS CELL DISSOCIATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 33. AMERICAS CELL DISSOCIATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 34. ARGENTINA CELL DISSOCIATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 35. ARGENTINA CELL DISSOCIATION MARKET SIZE, BY ENZYMATIC DISSOCIATION PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 36. ARGENTINA CELL DISSOCIATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 37. ARGENTINA CELL DISSOCIATION MARKET SIZE, BY TISSUE, 2018-2030 (USD MILLION)
  • TABLE 38. ARGENTINA CELL DISSOCIATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 39. BRAZIL CELL DISSOCIATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 40. BRAZIL CELL DISSOCIATION MARKET SIZE, BY ENZYMATIC DISSOCIATION PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 41. BRAZIL CELL DISSOCIATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 42. BRAZIL CELL DISSOCIATION MARKET SIZE, BY TISSUE, 2018-2030 (USD MILLION)
  • TABLE 43. BRAZIL CELL DISSOCIATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 44. CANADA CELL DISSOCIATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 45. CANADA CELL DISSOCIATION MARKET SIZE, BY ENZYMATIC DISSOCIATION PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 46. CANADA CELL DISSOCIATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 47. CANADA CELL DISSOCIATION MARKET SIZE, BY TISSUE, 2018-2030 (USD MILLION)
  • TABLE 48. CANADA CELL DISSOCIATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 49. MEXICO CELL DISSOCIATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 50. MEXICO CELL DISSOCIATION MARKET SIZE, BY ENZYMATIC DISSOCIATION PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 51. MEXICO CELL DISSOCIATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 52. MEXICO CELL DISSOCIATION MARKET SIZE, BY TISSUE, 2018-2030 (USD MILLION)
  • TABLE 53. MEXICO CELL DISSOCIATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 54. UNITED STATES CELL DISSOCIATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 55. UNITED STATES CELL DISSOCIATION MARKET SIZE, BY ENZYMATIC DISSOCIATION PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 56. UNITED STATES CELL DISSOCIATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 57. UNITED STATES CELL DISSOCIATION MARKET SIZE, BY TISSUE, 2018-2030 (USD MILLION)
  • TABLE 58. UNITED STATES CELL DISSOCIATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 59. UNITED STATES CELL DISSOCIATION MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 60. ASIA-PACIFIC CELL DISSOCIATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 61. ASIA-PACIFIC CELL DISSOCIATION MARKET SIZE, BY ENZYMATIC DISSOCIATION PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 62. ASIA-PACIFIC CELL DISSOCIATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 63. ASIA-PACIFIC CELL DISSOCIATION MARKET SIZE, BY TISSUE, 2018-2030 (USD MILLION)
  • TABLE 64. ASIA-PACIFIC CELL DISSOCIATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 65. ASIA-PACIFIC CELL DISSOCIATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 66. AUSTRALIA CELL DISSOCIATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 67. AUSTRALIA CELL DISSOCIATION MARKET SIZE, BY ENZYMATIC DISSOCIATION PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 68. AUSTRALIA CELL DISSOCIATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. AUSTRALIA CELL DISSOCIATION MARKET SIZE, BY TISSUE, 2018-2030 (USD MILLION)
  • TABLE 70. AUSTRALIA CELL DISSOCIATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 71. CHINA CELL DISSOCIATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 72. CHINA CELL DISSOCIATION MARKET SIZE, BY ENZYMATIC DISSOCIATION PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 73. CHINA CELL DISSOCIATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. CHINA CELL DISSOCIATION MARKET SIZE, BY TISSUE, 2018-2030 (USD MILLION)
  • TABLE 75. CHINA CELL DISSOCIATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 76. INDIA CELL DISSOCIATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 77. INDIA CELL DISSOCIATION MARKET SIZE, BY ENZYMATIC DISSOCIATION PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 78. INDIA CELL DISSOCIATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. INDIA CELL DISSOCIATION MARKET SIZE, BY TISSUE, 2018-2030 (USD MILLION)
  • TABLE 80. INDIA CELL DISSOCIATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 81. INDONESIA CELL DISSOCIATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 82. INDONESIA CELL DISSOCIATION MARKET SIZE, BY ENZYMATIC DISSOCIATION PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 83. INDONESIA CELL DISSOCIATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 84. INDONESIA CELL DISSOCIATION MARKET SIZE, BY TISSUE, 2018-2030 (USD MILLION)
  • TABLE 85. INDONESIA CELL DISSOCIATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 86. JAPAN CELL DISSOCIATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 87. JAPAN CELL DISSOCIATION MARKET SIZE, BY ENZYMATIC DISSOCIATION PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 88. JAPAN CELL DISSOCIATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. JAPAN CELL DISSOCIATION MARKET SIZE, BY TISSUE, 2018-2030 (USD MILLION)
  • TABLE 90. JAPAN CELL DISSOCIATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 91. MALAYSIA CELL DISSOCIATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 92. MALAYSIA CELL DISSOCIATION MARKET SIZE, BY ENZYMATIC DISSOCIATION PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 93. MALAYSIA CELL DISSOCIATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. MALAYSIA CELL DISSOCIATION MARKET SIZE, BY TISSUE, 2018-2030 (USD MILLION)
  • TABLE 95. MALAYSIA CELL DISSOCIATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 96. PHILIPPINES CELL DISSOCIATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 97. PHILIPPINES CELL DISSOCIATION MARKET SIZE, BY ENZYMATIC DISSOCIATION PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 98. PHILIPPINES CELL DISSOCIATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. PHILIPPINES CELL DISSOCIATION MARKET SIZE, BY TISSUE, 2018-2030 (USD MILLION)
  • TABLE 100. PHILIPPINES CELL DISSOCIATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 101. SINGAPORE CELL DISSOCIATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 102. SINGAPORE CELL DISSOCIATION MARKET SIZE, BY ENZYMATIC DISSOCIATION PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 103. SINGAPORE CELL DISSOCIATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 104. SINGAPORE CELL DISSOCIATION MARKET SIZE, BY TISSUE, 2018-2030 (USD MILLION)
  • TABLE 105. SINGAPORE CELL DISSOCIATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 106. SOUTH KOREA CELL DISSOCIATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 107. SOUTH KOREA CELL DISSOCIATION MARKET SIZE, BY ENZYMATIC DISSOCIATION PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 108. SOUTH KOREA CELL DISSOCIATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 109. SOUTH KOREA CELL DISSOCIATION MARKET SIZE, BY TISSUE, 2018-2030 (USD MILLION)
  • TABLE 110. SOUTH KOREA CELL DISSOCIATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 111. TAIWAN CELL DISSOCIATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 112. TAIWAN CELL DISSOCIATION MARKET SIZE, BY ENZYMATIC DISSOCIATION PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 113. TAIWAN CELL DISSOCIATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 114. TAIWAN CELL DISSOCIATION MARKET SIZE, BY TISSUE, 2018-2030 (USD MILLION)
  • TABLE 115. TAIWAN CELL DISSOCIATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 116. THAILAND CELL DISSOCIATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 117. THAILAND CELL DISSOCIATION MARKET SIZE, BY ENZYMATIC DISSOCIATION PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 118. THAILAND CELL DISSOCIATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 119. THAILAND CELL DISSOCIATION MARKET SIZE, BY TISSUE, 2018-2030 (USD MILLION)
  • TABLE 120. THAILAND CELL DISSOCIATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 121. VIETNAM CELL DISSOCIATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 122. VIETNAM CELL DISSOCIATION MARKET SIZE, BY ENZYMATIC DISSOCIATION PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 123. VIETNAM CELL DISSOCIATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 124. VIETNAM CELL DISSOCIATION MARKET SIZE, BY TISSUE, 2018-2030 (USD MILLION)
  • TABLE 125. VIETNAM CELL DISSOCIATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 126. EUROPE, MIDDLE EAST & AFRICA CELL DISSOCIATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 127. EUROPE, MIDDLE EAST & AFRICA CELL DISSOCIATION MARKET SIZE, BY ENZYMATIC DISSOCIATION PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 128. EUROPE, MIDDLE EAST & AFRICA CELL DISSOCIATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 129. EUROPE, MIDDLE EAST & AFRICA CELL DISSOCIATION MARKET SIZE, BY TISSUE, 2018-2030 (USD MILLION)
  • TABLE 130. EUROPE, MIDDLE EAST & AFRICA CELL DISSOCIATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 131. EUROPE, MIDDLE EAST & AFRICA CELL DISSOCIATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 132. DENMARK CELL DISSOCIATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 133. DENMARK CELL DISSOCIATION MARKET SIZE, BY ENZYMATIC DISSOCIATION PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 134. DENMARK CELL DISSOCIATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 135. DENMARK CELL DISSOCIATION MARKET SIZE, BY TISSUE, 2018-2030 (USD MILLION)
  • TABLE 136. DENMARK CELL DISSOCIATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 137. EGYPT CELL DISSOCIATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 138. EGYPT CELL DISSOCIATION MARKET SIZE, BY ENZYMATIC DISSOCIATION PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 139. EGYPT CELL DISSOCIATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 140. EGYPT CELL DISSOCIATION MARKET SIZE, BY TISSUE, 2018-2030 (USD MILLION)
  • TABLE 141. EGYPT CELL DISSOCIATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 142. FINLAND CELL DISSOCIATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 143. FINLAND CELL DISSOCIATION MARKET SIZE, BY ENZYMATIC DISSOCIATION PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 144. FINLAND CELL DISSOCIATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 145. FINLAND CELL DISSOCIATION MARKET SIZE, BY TISSUE, 2018-2030 (USD MILLION)
  • TABLE 146. FINLAND CELL DISSOCIATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 147. FRANCE CELL DISSOCIATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 148. FRANCE CELL DISSOCIATION MARKET SIZE, BY ENZYMATIC DISSOCIATION PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 149. FRANCE CELL DISSOCIATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 150. FRANCE CELL DISSOCIATION MARKET SIZE, BY TISSUE, 2018-2030 (USD MILLION)
  • TABLE 151. FRANCE CELL DISSOCIATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 152. GERMANY CELL DISSOCIATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 153. GERMANY CELL DISSOCIATION MARKET SIZE, BY ENZYMATIC DISSOCIATION PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 154. GERMANY CELL DISSOCIATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 155. GERMANY CELL DISSOCIATION MARKET SIZE, BY TISSUE, 2018-2030 (USD MILLION)
  • TABLE 156. GERMANY CELL DISSOCIATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 157. ISRAEL CELL DISSOCIATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 158. ISRAEL CELL DISSOCIATION MARKET SIZE, BY ENZYMATIC DISSOCIATION PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 159. ISRAEL CELL DISSOCIATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 160. ISRAEL CELL DISSOCIATION MARKET SIZE, BY TISSUE, 2018-2030 (USD MILLION)
  • TABLE 161. ISRAEL CELL DISSOCIATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 162. ITALY CELL DISSOCIATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 163. ITALY CELL DISSOCIATION MARKET SIZE, BY ENZYMATIC DISSOCIATION PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 164. ITALY CELL DISSOCIATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 165. ITALY CELL DISSOCIATION MARKET SIZE, BY TISSUE, 2018-2030 (USD MILLION)
  • TABLE 166. ITALY CELL DISSOCIATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 167. NETHERLANDS CELL DISSOCIATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 168. NETHERLANDS CELL DISSOCIATION MARKET SIZE, BY ENZYMATIC DISSOCIATION PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 169. NETHERLANDS CELL DISSOCIATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 170. NETHERLANDS CELL DISSOCIATION MARKET SIZE, BY TISSUE, 2018-2030 (USD MILLION)
  • TABLE 171. NETHERLANDS CELL DISSOCIATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 172. NIGERIA CELL DISSOCIATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 173. NIGERIA CELL DISSOCIATION MARKET SIZE, BY ENZYMATIC DISSOCIATION PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 174. NIGERIA CELL DISSOCIATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 175. NIGERIA CELL DISSOCIATION MARKET SIZE, BY TISSUE, 2018-2030 (USD MILLION)
  • TABLE 176. NIGERIA CELL DISSOCIATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 177. NORWAY CELL DISSOCIATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 178. NORWAY CELL DISSOCIATION MARKET SIZE, BY ENZYMATIC DISSOCIATION PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 179. NORWAY CELL DISSOCIATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 180. NORWAY CELL DISSOCIATION MARKET SIZE, BY TISSUE, 2018-2030 (USD MILLION)
  • TABLE 181. NORWAY CELL DISSOCIATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 182. POLAND CELL DISSOCIATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 183. POLAND CELL DISSOCIATION MARKET SIZE, BY ENZYMATIC DISSOCIATION PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 184. POLAND CELL DISSOCIATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 185. POLAND CELL DISSOCIATION MARKET SIZE, BY TISSUE, 2018-2030 (USD MILLION)
  • TABLE 186. POLAND CELL DISSOCIATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 187. QATAR CELL DISSOCIATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 188. QATAR CELL DISSOCIATION MARKET SIZE, BY ENZYMATIC DISSOCIATION PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 189. QATAR CELL DISSOCIATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 190. QATAR CELL DISSOCIATION MARKET SIZE, BY TISSUE, 2018-2030 (USD MILLION)
  • TABLE 191. QATAR CELL DISSOCIATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 192. RUSSIA CELL DISSOCIATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 193. RUSSIA CELL DISSOCIATION MARKET SIZE, BY ENZYMATIC DISSOCIATION PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 194. RUSSIA CELL DISSOCIATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 195. RUSSIA CELL DISSOCIATION MARKET SIZE, BY TISSUE, 2018-2030 (USD MILLION)
  • TABLE 196. RUSSIA CELL DISSOCIATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 197. SAUDI ARABIA CELL DISSOCIATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 198. SAUDI ARABIA CELL DISSOCIATION MARKET SIZE, BY ENZYMATIC DISSOCIATION PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 199. SAUDI ARABIA CELL DISSOCIATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 200. SAUDI ARABIA CELL DISSOCIATION MARKET SIZE, BY TISSUE, 2018-2030 (USD MILLION)
  • TABLE 201. SAUDI ARABIA CELL DISSOCIATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 202. SOUTH AFRICA CELL DISSOCIATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 203. SOUTH AFRICA CELL DISSOCIATION MARKET SIZE, BY ENZYMATIC DISSOCIATION PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 204. SOUTH AFRICA CELL DISSOCIATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 205. SOUTH AFRICA CELL DISSOCIATION MARKET SIZE, BY TISSUE, 2018-2030 (USD MILLION)
  • TABLE 206. SOUTH AFRICA CELL DISSOCIATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 207. SPAIN CELL DISSOCIATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 208. SPAIN CELL DISSOCIATION MARKET SIZE, BY ENZYMATIC DISSOCIATION PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 209. SPAIN CELL DISSOCIATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 210. SPAIN CELL DISSOCIATION MARKET SIZE, BY TISSUE, 2018-2030 (USD MILLION)
  • TABLE 211. SPAIN CELL DISSOCIATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 212. SWEDEN CELL DISSOCIATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 213. SWEDEN CELL DISSOCIATION MARKET SIZE, BY ENZYMATIC DISSOCIATION PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 214. SWEDEN CELL DISSOCIATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 215. SWEDEN CELL DISSOCIATION MARKET SIZE, BY TISSUE, 2018-2030 (USD MILLION)
  • TABLE 216. SWEDEN CELL DISSOCIATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 217. SWITZERLAND CELL DISSOCIATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 218. SWITZERLAND CELL DISSOCIATION MARKET SIZE, BY ENZYMATIC DISSOCIATION PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 219. SWITZERLAND CELL DISSOCIATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 220. SWITZERLAND CELL DISSOCIATION MARKET SIZE, BY TISSUE, 2018-2030 (USD MILLION)
  • TABLE 221. SWITZERLAND CELL DISSOCIATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 222. TURKEY CELL DISSOCIATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 223. TURKEY CELL DISSOCIATION MARKET SIZE, BY ENZYMATIC DISSOCIATION PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 224. TURKEY CELL DISSOCIATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 225. TURKEY CELL DISSOCIATION MARKET SIZE, BY TISSUE, 2018-2030 (USD MILLION)
  • TABLE 226. TURKEY CELL DISSOCIATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 227. UNITED ARAB EMIRATES CELL DISSOCIATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 228. UNITED ARAB EMIRATES CELL DISSOCIATION MARKET SIZE, BY ENZYMATIC DISSOCIATION PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 229. UNITED ARAB EMIRATES CELL DISSOCIATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 230. UNITED ARAB EMIRATES CELL DISSOCIATION MARKET SIZE, BY TISSUE, 2018-2030 (USD MILLION)
  • TABLE 231. UNITED ARAB EMIRATES CELL DISSOCIATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 232. UNITED KINGDOM CELL DISSOCIATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 233. UNITED KINGDOM CELL DISSOCIATION MARKET SIZE, BY ENZYMATIC DISSOCIATION PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 234. UNITED KINGDOM CELL DISSOCIATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 235. UNITED KINGDOM CELL DISSOCIATION MARKET SIZE, BY TISSUE, 2018-2030 (USD MILLION)
  • TABLE 236. UNITED KINGDOM CELL DISSOCIATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 237. CELL DISSOCIATION MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 238. CELL DISSOCIATION MARKET, FPNV POSITIONING MATRIX, 2023